ESCUDDO Trial - NCI
The ESCUDDO Efficacy Trial is a scientific evaluation of one or two doses of the human papillomavirus (HPV) bivalent or nonavalent prophylactic vaccines| dceg.cancer.gov
The ESCUDDO Efficacy Trial is a scientific evaluation of one or two doses of the human papillomavirus (HPV) bivalent or nonavalent prophylactic vaccines| dceg.cancer.gov
In the U.S., HPV infections are estimated to cause about 37,300 cases of cancer. The HPV vaccine can prevent over 90% of these cancers from ever developing.| American Sexual Health Association
Though usually harmless, some types of HPV cause cervical lesions that, over a period of time, can develop into cancer if untreated.| American Sexual Health Association
